Condition: Breast Cancer · Breast Cancer Female · Sponsor: Breast Cancer Trials, Australia and New Zealand
The PROSPECTIVE trial aims to find out if using the results of Magnetic Resonance Imaging (MRI) for early breast cancer can select people to not have radiotherapy and still have a low chance of the cancer coming back after surgery. The main question it aims to answer is: \* Will cancer come back in the same breast as the original cancer in patients who have surgery for their breast cancer, but who don't have radiotherapy afterwards because the results of an MRI before surgery showed favourable characteristics for not having radiotherapy.
This description comes directly from the study's public registry record.
Heath Badger · +61 2 4925 5239 · heath.badger@bctrials.org.au
Always discuss trial participation with your own doctor first.
| UCSF Breast Care Center | San Francisco, California, United States | Not Yet Recruiting |
| Baylor St Luke's Medical Centre | Houston, Texas, United States | Not Yet Recruiting |
| The Chris O'Brien Lifehouse | Camperdown, New South Wales, Australia | Not Yet Recruiting |
| Lake Macquarie Private Hospital | Gateshead, New South Wales, Australia | Not Yet Recruiting |
| Mater Hospital, Sydney | North Sydney, New South Wales, Australia | Recruiting |
| Westmead Hospital | Westmead, New South Wales, Australia | Not Yet Recruiting |
| Royal Adelaide Hospital | Adelaide, South Australia, Australia | Not Yet Recruiting |
| Monash Cancer Centre (MMC Moorabbin) | Clayton, Victoria, Australia | Recruiting |
| The Royal Melbourne Hospital | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06445738